Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 5;6(12):e202302148.
doi: 10.26508/lsa.202302148. Print 2023 Dec.

Activation of the JNK/COX-2/HIF-1α axis promotes M1 macrophage via glycolytic shift in HIV-1 infection

Affiliations

Activation of the JNK/COX-2/HIF-1α axis promotes M1 macrophage via glycolytic shift in HIV-1 infection

Junhan Zhang et al. Life Sci Alliance. .

Abstract

Chronic inflammation is recognized as a major risk factor for the severity of HIV infection. Whether metabolism reprogramming of macrophages caused by HIV-1 is related to chronic inflammatory activation, especially M1 polarization of macrophages, is inconclusive. Here, we show that HIV-1 infection induces M1 polarization and enhanced glycolysis in macrophages. Blockade of glycolysis inhibits M1 polarization of macrophages, indicating that HIV-1-induced M1 polarization is supported by enhanced glycolysis. Moreover, we find that this immunometabolic adaptation is dependent on hypoxia-inducible factor 1α (HIF-1α), a strong inducer of glycolysis. HIF-1α-target genes, including HK2, PDK1, and LDHA, are also involved in this process. Further research discovers that COX-2 regulates HIF-1α-dependent glycolysis. However, the elevated expression of COX-2, enhanced glycolysis, and M1 polarization of macrophages could be reversed by inactivation of JNK in the context of HIV-1 infection. Our study mechanistically elucidates that the JNK/COX-2/HIF-1α axis is activated to strengthen glycolysis, thereby promoting M1 polarization in macrophages in HIV-1 infection, providing a new idea for resolving chronic inflammation in clinical AIDS patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

None
Graphical abstract
Figure 1.
Figure 1.. HIV-1 infection induces M1 polarization of macrophages.
(A) Morphologic features of monocyte-derived macrophages (MDMs) after HIV-1 infection for 1–3 d. Scale bar, 100 μm. (B, C) Changes in mRNA (B) and protein expressions (C) of M1 and M2 polarization markers in MDMs after HIV-1 infection for 1–3 d. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001.) (D) Representative results of expressions of M1 and M2 polarization markers in MDMs detected by flow cytometry. (Statistical analysis was performed using a t test, *P < 0.05).
Figure S1.
Figure S1.. Impacts of HIV-1 on monocyte-derived macrophages are similar to LPS and IFN-γ co-stimulation.
THP-1 cells were seeded in a culture plate with PMA (50 μM) stimulation (48 h) to differentiate macrophages. LPS (1 μg/ml) and IFN-γ (20 mg/ml) were co-used for typical M1 polarization, whereas IL-4 (20 mg/ml) was used in combination with IL-10 (20 mg/ml) for M2 polarization. (A) Immunofluorescence staining of DAPI (representing nucleus) and β-actin (representing cytoskeleton) was used to observe morphological changes in macrophages with different stimuli for 48 h. Scale bar, 150 μm. (B) RT–qPCR analysis showed the mRNA levels of TNF-α, IL-1β, and IL-6 in THP-1 macrophages after 2 d (upper) and 3 d (bottom) of stimulation. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001).
Figure 2.
Figure 2.. Metabolism reprogramming affects polarization in HIV-1–infected macrophages.
(A) ATP/ADP ratio (left panel) and relative ATP production from glycolysis and oxidative phosphorylation (right panel) in monocyte-derived macrophages (MDMs) infected or uninfected with HIV-1. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001.) (B) Representative results of glucose uptake analyzed by flow cytometry. (Statistical analysis was performed using a t test, ***P < 0.001.) (C) Lactate concentration in the supernatant of MDMs infected with HIV-1 for 48 h was detected using colorimetry. (Statistical analysis was performed using a t test, ***P < 0.001.) (D, E) Extracellular acidification rate and oxygen consumption rate of MDMs infected with HIV-1 for 48 h. Time-resolved fluorescence was applied and monitored for 120 min. Results were relative to 0 min. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001.) (F) Mitochondrial membrane potential was assessed using the JC-1 assay. A change from red to green fluorescence indicates a decrease in the mitochondrial membrane potential. The red/green fluorescence ratio was calculated for comparison. (Statistical analysis was performed using a t test, **P < 0.01.) Scale bar, 300 μm. (G) Bar plot showed glycolytic index (GI) differences in control and HIV-1–infected MDMs. (H) mRNA expressions of key genes in TCA and oxidative phosphorylation. (Statistical analysis was performed using a t test, ns non-significant, *P < 0.05, **P < 0.01, and ***P < 0.001.) (I, J) MDMs were pretreated with or without 2-DG (10 mM) for 2 h, followed by infection of HIV-1 for 48 h. (I, J) Lactate concentration in the culture supernatant (I), and mRNA expressions of TNF-α, IL-1β, and IL-6 (J) were detected. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001).
Figure S2.
Figure S2.. Heptelidic acid inhibits glycolysis and inflammation induced by HIV-1 infection, whereas oligomycin exerts the opposite effect.
Monocyte-derived macrophages were treated with 10 μM heptelidic acid (HA) or 40 μM oligomycin (Omy) for 8 h during the 48 h of HIV-1 infection. (A, B, C, D) Lactate concentration in the culture supernatant (A), and expressions of TNF-α, IL-1β, and IL-6 (B, C, D) were detected. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001 as compared to Control; #P < 0.05, ##P < 0.01, and ###P < 0.001 as compared to HIV-1).
Figure 3.
Figure 3.. Activation of HIF-1ɑ impinges upon gene regulation of glucose metabolism.
(A) Immunofluorescence showed HIF-1ɑ protein localization and expression in monocyte-derived macrophages (MDMs). Blue: DAPI; green: HIF-1ɑ. Scale bar, 300 μm. (B, C) MDMs were pretreated with or without LW6 (15 μM) for 2 h, followed by HIV-1 infection for another 48 h. (B, C) RT–qPCR analysis showed the mRNA levels of key genes in the glycolysis (B) and TCA cycle (C). (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001.) (D, E) MDMs treated with or without YC-1 (1 μM) and infected with or without HIV-1 were assessed for expressions of key genes in the glycolysis (D) and TCA cycle (E). (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001).
Figure 4.
Figure 4.. Effect of HIF-1ɑ inhibition on glycolysis, mitochondrial activity, and M1 polarization in monocyte-derived macrophages (MDMs).
MDMs were infected with HIV-1 for 48 h, in the presence or absence of LW6 (15 μM) pretreatment (2 h). (A) Lactate concentration in the culture supernatant of MDMs. (Statistical analysis was performed using a t test, **P < 0.01 and ***P < 0.001.) (B) Mitochondrial membrane potential was assessed by the JC-1 assay. (Statistical analysis was performed using a t test, *P < 0.05.) Scale bar, 100 μm. (C, D) mRNA (C) and protein levels (D) of TNF-α, IL-1β, and IL-6 were detected using RT–qPCR and ELISA, respectively. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001).
Figure 5.
Figure 5.. Activation of COX-2 mediates HIF-1ɑ–dependent glucose metabolism reprogramming and M1 polarization in monocyte-derived macrophages (MDMs).
(A, B) mRNA (A) and protein expressions (B) of COX-2 in MDMs after HIV-1 infection for 48 h. β-Actin was used as the normalization control in Western blot analysis. (Statistical analysis was performed using a t test, **P < 0.001.) (C, D, E, F, G, H, I) MDMs were pretreated with meloxicam (50 μM) for 2 h; then, HIV-1 particles were added to incubate for another 48 h. COX-2 expression (C), lactate production (D), key glycolytic gene expression (E), hypoxia-inducible factor 1α expression ((F), scale bar, 300 μm), and M1 polarization (H, I) were measured. (G) Quantification of hypoxia-inducible factor 1α fluorescence intensity. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001).
Figure 6.
Figure 6.. Knockdown of COX-2 represses HIF-1ɑ–dependent glycolytic shift and M1 polarization in THP-1 macrophages.
(A) EGFP fluorescence of THP-1 macrophages transfected with lentivirus. (B, C) COX-2–silencing THP-1 macrophages were verified by RT–qPCR and Western blot. (Statistical analysis was performed using a t test, **P < 0.01.) (D, E, F, G) HIF-1ɑ expression (D), lactate production (E), and mRNA and protein expressions of TNF-α, IL-1β, and IL-6 (F, G) were decreased in COX-2–silencing THP-1 macrophages, as quantified by RT–qPCR and ELISA. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001).
Figure 7.
Figure 7.. HIV-1 urges phosphorylation of JNK in macrophages.
THP-1 macrophages and primary monocyte-derived macrophages (MDMs) were infected with or without HIV-1 for 48 h. (A) KEGG enrichment analysis of differentially expressed genes in HIV-1–infected THP-1 macrophages and control macrophages. The size of the bubble positively correlated with the number of enriched genes. The x-axis represents the gene ratio, and the color of the bubble represents the adjusted P-value of enrichment analysis. (B) Gene set enrichment analysis was performed in Control and HIV-1 groups. In this figure, the y-axis represents enrichment score (ES), and on the x-axis are genes (vertical black lines) included in gene sets. The analysis demonstrates that the MAPK signaling pathway is enriched in the HIV-1 group (NES = 1.315, P-value < 0.0001, FDR = 0.301). The detailed information is provided in Table S1. (C) RT–qPCR analysis showed the mRNA levels of JNK, ERK, and p38 in MDMs. (Statistical analysis was performed using a t test, *P < 0.05.) (D, E) Western blot confirmed phosphorylation of JNK is increased in MDMs (D) and THP-1 macrophages (E) upon HIV-1 infection. (Statistical analysis was performed using a t test, *P < 0.05).
Figure 8.
Figure 8.. SP600125 reverses HIV-1–induced M1 polarization by inhibiting JNK activation.
Monocyte-derived macrophages (MDMs) were pretreated with or without SP600125 (50 μM) for 2 h, followed by infection of HIV-1 for 48 h. (A) Expressions of JNK and COX-2 were measured by Western blot. Total JNK was used as the normalization control of phosphorylated JNK, and β-actin was used as the normalization control of COX-2. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001.) (B) Western blot analysis of hypoxia-inducible factor 1α, HK1, HK2, and LDHA in MDMs. β-Actin was used as the normalization control. SP600125, meloxicam, LW6, and YC-1 were administered as mentioned above. (Statistical analysis was performed using a t test, *P < 0.05 and **P < 0.01 as compared to Control; #P < 0.05, ##P < 0.01, and ###P < 0.001 as compared to HIV-1.) (C) Lactate concentration in the culture supernatant of MDMs was detected using colorimetry. (Statistical analysis was performed using a t test, *P < 0.05 and ***P < 0.001.) (D, E) MDMs were collected, and the expression of TNF-α, IL-1β, and IL-6 was measured by RT–qPCR (D) and ELISA (E). (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001).
Figure S3.
Figure S3.. Blockade of glycolysis inhibits HIV-1 replication.
Monocyte-derived macrophages were pretreated with or without 2-DG (10 mM) for 2 h, followed by infection of HIV-1 for 48 h. The content of p24 protein in the supernatant was detected by ELISA. (Statistical analysis was performed using a t test, *P < 0.05, **P < 0.01, and ***P < 0.001).

References

    1. Angin M, Volant S, Passaes C, Lecuroux C, Monceaux V, Dillies MA, Valle-Casuso JC, Pancino G, Vaslin B, Le Grand R, et al. (2019) Metabolic plasticity of HIV-specific CD8(+) T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection. Nat Metab 1: 704–716. 10.1038/s42255-019-0081-4 - DOI - PubMed
    1. Barker E, Mackewicz CE, Reyes-Terán G, Sato A, Stranford SA, Fujimura SH, Christopherson C, Chang SY, Levy JA (1998) Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 92: 3105–3114. 10.1182/blood.v92.9.3105 - DOI - PubMed
    1. Bengal E, Aviram S, Hayek T (2020) p38 MAPK in glucose metabolism of skeletal muscle: Beneficial or harmful? Int J Mol Sci 21: 6480. 10.3390/ijms21186480 - DOI - PMC - PubMed
    1. Burrack KS, Morrison TE (2014) The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases. Front Immunol 5: 428. 10.3389/fimmu.2014.00428 - DOI - PMC - PubMed
    1. Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75: 50–83. 10.1128/mmbr.00031-10 - DOI - PMC - PubMed

Publication types

Substances